The 30-month period during which an ANDA first-filer must obtain tentative approval or face forfeiture of its rights to 180-day marketing exclusivity begins to run on the day after the application is filed, FDA said in a Jan. 26 citizen petition response.
In a June 2012 petition, Sandoz Inc. challenged Ranbaxy Laboratories Ltd.’s eligibility for generic marketing exclusivity on
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?